The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kovalenko N.V.

Volgograd State Medical University

Mozgovoy P.V.

Volgograd State Medical University

Yagupov R.P.

Volgograd State Medical University

Vorontsov O.F.

Volgograd State Medical University;
Sana Klinikum Hof

Mikhin I.V.

Volgograd State Medical University

Radeleff B.

Sana Klinikum Hof

Global trends in endovascular treatment of patients with malignant neoplasms and metastatic liver damage

Authors:

Kovalenko N.V., Mozgovoy P.V., Yagupov R.P., Vorontsov O.F., Mikhin I.V., Radeleff B.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2023;(9): 72‑78

DOI: 10.17116/hirurgia202309172

Views: 1425

Downloaded: 20

Download PDF (RU)
Contact the author
Table of contents

GLOBAL TRENDS IN ENDOVASCULAR TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS AND METASTATIC LIVER DAMAGE
GLOBAL TRENDS IN ENDOVASCULAR TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS AND METASTATIC LIVER DAMAGE

To cite this article:

Kovalenko NV, Mozgovoy PV, Yagupov RP, Vorontsov OF, Mikhin IV, Radeleff B. Global trends in endovascular treatment of patients with malignant neoplasms and metastatic liver damage. Pirogov Russian Journal of Surgery. 2023;(9):72‑78. (In Russ.)
https://doi.org/10.17116/hirurgia202309172

 
Подписка 2025-2 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
Surgical treatment of traumatic arte­riovenous fistulas of extremities. Piro­gov Russian Journal of Surgery. 2024;(7):92-102
Endo­vascular technologies in the treatment of patients with blunt abdo­minal trauma. Piro­gov Russian Journal of Surgery. 2024;(8):108-117
Treatment of postoperative complications in cardiothoracic surgery: single-center 10-year expe­rience. Piro­gov Russian Journal of Surgery. 2024;(12-2):66-71
Cere­bral protection in transcatheter aortic valve implantation. Piro­gov Russian Journal of Surgery. 2024;(12-2):150-158
Modern approaches in endo­vascular and endo­scopic treatment of isolated sple­nic injury. Piro­gov Russian Journal of Surgery. 2024;(12):5-12
Reco­nstructive plastic surgery in combined treatment of breast cancer: predictive risk factors of complications and reco­nstruction failure. P.A. Herzen Journal of Onco­logy. 2024;(3):13-19
Role of acute kidney injury in the treatment of acute lower limb ischemia. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):457-462
Hypoalbuminemia as an inde­pendent predictor of complications, critical illness and premature death. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):83-89
Safety profile of pressurized intraperitoneal aero­sol chemotherapy in the treatment of ovarian cancer. P.A. Herzen Journal of Onco­logy. 2024;(5):25-30
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83

OBJECTIVE

To analyze the results of endovascular embolization of malignant tumors and liver metastases.

MATERIAL AND METHODS

We analyzed international studies on the treatment of patients with neoplastic liver lesions and complications after regional endovascular embolization following leakage of chemotherapeutic drugs from the target vessel and negative systemic effects. The results of embolization of liver arteries without chemotherapeutic drugs were also analyzed. We reviewed the PubMed, The Cochrane Library, Web of Science databases, as well as Russian scientific and practical journals.

CONCLUSION

Literature data indicate high clinical effectiveness of interventional treatment of patients with malignant neoplasms and metastatic liver damage.

Keywords:

hepatocellular cancer
minimally invasive endovascular methods of treatment
transarterial chemoembolization
infusion chemotherapy
hemoperitoneum
embolization
complications
bleeding following hepatocellular carcinoma rupture

Authors:

Kovalenko N.V.

Volgograd State Medical University

Mozgovoy P.V.

Volgograd State Medical University

Yagupov R.P.

Volgograd State Medical University

Vorontsov O.F.

Volgograd State Medical University;
Sana Klinikum Hof

Mikhin I.V.

Volgograd State Medical University

Radeleff B.

Sana Klinikum Hof

Received:

26.01.2023

Accepted:

14.02.2023

List of references:

  1. Kotiv BN, Alentyev SA, Dzidzava II, Ivanusa SYa, Lazutkin MV, Slobodyanik AV, Muzharovsky AL, Sveklov DA. Preoperative Portal Vein Embolization in the Combined Treatment of Malignant Liver Tumor. Annals of HPB Surgery. 2016;21(3):12-19. (In Russ.). https://doi.org/10.16931/1995-5464.2016312-19
  2. Voskanyan SAe, Chuchuev ES, Artem’ev AI, Zabezhinskiyi DA, Bashkov AN, Zhurbin AS, Rudakov VS, Cholakyan SV. Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) v lechenii ochagovykh obrazovaniy pecheni. Khirurgiya. Zhurnal im. N.I. Pirogova. 2018;(2):39-44. (In Russ.). https://doi.org/10.17116/hirurgia2018239-44
  3. Cherkasov GE, Bagmet NN, Solovyeva IN, Shatveryan GA. Taktika krovosberezheniya pri obshirnykh rezektsiyakh pecheni. Khirurgiya. Zhurnal im. N.I. Pirogova. 2020;(7):111-118. (In Russ.). https://doi.org/10.17116/hirurgia2020071111
  4. Melekhina OV, Kulezneva YuV, Efanov MG, Musatov AB. Combined minimally invasive treatment of liver and bile ducts malignancies. Annals of HPB Surgery. 2018;23(2):26-36. (In Russ.). https://doi.org/10.16931/1995-5464.2018226-36
  5. Tyagun VS. Anatomicheskoye obosnovanii izolirovannoy dolevoy perfuzii pecheni pri yeyo metastaticheskom porazhenii (eksperimental’no-morfologicheskoye issledovaniye): Dis. ... kand. med. nauk. SPb. 2021. (In Russ.).
  6. Stukalova OYu, Guens GP, Shugushev ZKh. Role of hepatic arterial chemoembolization in the treatment of elderly and geriatric patients with metastatic colorectal cancer. Annals of HPB Surgery. 2021;26(2):83-90. (In Russ.). https://doi.org/10.16931/10.16931/1995-5464.2021-2-83-90
  7. Kotiv BN, Dzidzava II, Alent’yev SA, Smorodsky AV, Makhmudov KI, Apollonov AA, Soldatov SA, Zubarev PN. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stages. Annals of HPB Surgery. 2020;25(2):55-66. (In Russ.). https://doi.org/10.16931/1995-5464.2020255-66
  8. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad HM, Marrero JA. AASLD Guidelines for the Treatmentof Hepatocellular Carcinoma. Practice Guideline. Hepatology. 2018:67(1):358-380.  https://doi.org/10.1002/hep.29086
  9. Breder VV, Balachnin PV, Virshke ER, Kosirev VJu, Ledin EV, Petkau VV. Practical recommendations for the drug treatment of patients with hepatocellular cancer. Russian Society of Clinical Oncology (RUSSCO). 2020;21. (In Russ.). https://doi.org/10.18027/2224-5057-2020-10-3s2-25
  10. Lucatelli P, Burrel M, Guiu B, Rubeis G, Delden OV, Helmberger T. CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation. CIRSE Standarts of Practice Guidelines. Cardiovascular and interventional Radiology. 2021;44:1851-1867. https://doi.org/10.1007/s00270-021-02968-11
  11. Quinto AM, Nutu OA, Manso RSR, Alonso IJ, Pulido JC, Municio AM, García-Sesma A, Segurola CL, Caballero JM, Romero LCJ. Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors. Cirugia espanola (Engl Ed). 2018;96(9):560-567.  https://doi.org/10.1016/j.cireng.2018.10.017
  12. Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y. Randomised. Multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2020;69(8):1492-1501. https://doi.org/10.1136/gutjnl-2019-318934
  13. Shi Z, Yang W, Tang H, Xiuhong Li X. Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis. Medicine. 2021;100(20):e25851. https://doi.org/10.1097/MD.0000000000025851
  14. Tsai WL, Sun WC, Chen WC, Chiang CL, Lin HS, Liang HL, Cheng JS. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma. Medicine. 2020;99(32):e21489. https://doi.org/10.1097/MD.0000000000021489
  15. Hu J, Bao Q, Cao G, Zhu X, Yang R, Ji X, Xu L, Zheng K, Li W, Xing B, Wang X. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis. Cardiovascular and interventional Radiology. 2020;43(7):996-1005. https://doi.org/10.1007/s00270-019-02406-3
  16. Tartaglia N, Lascia AD, Cianci P, Fersini A, Pacilli M, Pavone G, Ambrosi A. Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review. Review Open Medicine (Wars).2020;15(1):739-744.  https://doi.org/10.1515/med-2020-0202
  17. Gala K, Guardiola-Bright J, McGee S. Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma. Cureus. 2020;12(4):e7750. https://doi.org/10.7759/cureus.7750
  18. Zhang H, Sun Y, Xu H, Liu J, Zhai H, Lu C, Zhao X, Chen Y, Zhou L, Han J. Endpoint of embolization: A study of transarterial chemoembolization in patients with large hepatocellular carcinoma. Official Journal of Balkan Union of Oncology. 2019;24(5):1970-1978.
  19. Lee S, Kim KM, Lee SJ, Lee KH, Lee DY, Kim MD, Kim DY, Kim SU, Won JY. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study. Acta Radiologica. 2017;58(2):131-139.  https://doi.org/10.1177/0284185116648501
  20. Patidar Y, Khisti R, Yadav A, Mukund A, Sarin SK. Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma. The Indian Journal of Radiolgy and Imaging. 2019;29(2):177-181.  https://doi.org/10.4103/ijri.IJRI_252_18
  21. Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U. Rupture of Hepatocellular Carcinoma: A Review of Literature. Journal of clinical and experimental Hepatology. 2019;9(2):245-256.  https://doi.org/10.1016/j.jceh.2018.04.002
  22. Wu PZ, Zhou J, Zhang YW. Gelatin sponge microparticles for the treatment of the spontaneous rupture of hepatocellular carcinoma hemorrhage. Experimental and Therapeutic Medicine. 2016;12(4):2201-2207. https://doi.org/10.3892/etm.2016.3573
  23. Chang Y, Jeong SW, Jang JY, Kim YJ. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2020;21(21):8165. https://doi.org/10.3390/ijms21218165
  24. Yang B, Jie L, Yang T, Chen M, Gao Y, Zhang T, Zhang Y, Wu H, Liao Z. TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study. Frontiers in oncology. 2021;11:821599. https://doi.org/10.3389/fonc.2021.821599

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.